Cardiologist, epidemiologist and population health pioneer Salim Yusuf has transformed how we treat and prevent chronic disease.
Under his leadership, the Population Health Research Institute (PHRI) has become Canada’s premiere global health research institute, a world leader in large-scale clinical trials and population studies. Its focus has broadened from cardiovascular disease and diabetes to include population genomics, perioperative medicine, stroke, thrombosis, cardiovascular surgery, renal, obesity, childhood obesity, and implementation science. PHRI studies have enrolled close to two million participants worldwide, with researchers in more than 100 countries.
Dr. Yusuf recently led a major international study that found that cancer has overtaken cardiovascular disease as the major cause of death among middle-aged adults in high-income countries, likely because of better-quality health care.
Under his leadership, the Population Health Research Institute (PHRI) has become Canada’s premiere global health research institute, a world leader in large-scale clinical trials and population studies. Its focus has broadened from cardiovascular disease and diabetes to include population genomics, perioperative medicine, stroke, thrombosis, cardiovascular surgery, renal, obesity, childhood obesity, and implementation science. PHRI studies have enrolled close to two million participants worldwide, with researchers in more than 100 countries.
Dr. Yusuf recently led a major international study that found that cancer has overtaken cardiovascular disease as the major cause of death among middle-aged adults in high-income countries, likely because of better-quality health care.